Improvement of Endothelial Function in Patients with Hypercholesterolemia and Normal Coronary Arteries with Lipid-Lowering Therapy;Mejoría de la función endotelial al reducir las concentraciones lipídicas en pacientes con hipercolesterolemia y arterias coronarias normales

Revista Espanola de Cardiologia

Volumn 54, Issue 6, 2001, Pages 685-692

  Iràculis, Emili ^a   Cequier, Ángel ^a,b   Sabaté, Manel ^a   Pintó, Xavier ^a   Gómez Hospital, Joan Antoni ^a   Mauri, Josepa ^a   García Del Blanco, Bruno ^a   Fernández Nofrerias, Eduard ^a   Palom, Xavier ^a   Jara, Francesc ^a   Esplugas, Enric ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; BLOOD; CORONARY BLOOD VESSEL; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ADULT; AGED; CHOLESTEROL; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; TRIGLYCERIDES; VASODILATOR AGENTS;

EID: 0035374551     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(01)76383-x     Document Type: Article

References (35)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol lipoproteins, and the risk of coronary heart disease: The Framingam Study. Ann Intern Med 1971; 74: 1-12.
2. Steinbrecher UP, Parthasarathy S, Leake DS, Witzum JL, Steinberg D. Modification of low density lipoproteins by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-3887.
3. Anderson TJ, Meredith IT, Charbonneau F, Yeung AC, Frei B, Selwyn AP et al. Endothelium-dependent coronary vasomotion relates to the susceptibity of LDL to oxidation in humans. Circulation 1996; 93; 1647-1650.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
5. Brown G, Albers JJ, Fisher LD. Regression of coronary artery disease as a result of an intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298.
6. Chappell SP, Lewis MJ, Henderson AH. Effect of lipid feeding on endothelium dependent relaxion in rabbit aortic preparations. Cardiovasc Res 1987; 21: 34-38.
7. Kugiyama K, Kerns SA, Morriset JD, Robers R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecitin in modified low density lipoproteins. Nature 1990; 344: 160-162.
8. Luscher TF. The endothelium and cardiovascular disease -a complex relation. N Engl J Med 1994; 330: 1081-1083.
9. Cooke JP, Tsao PS. Is NO an endougenous antiatherogenic molecule? Arterioscler Thromb 1994; 14: 653-655.
10. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW et al. Paradoxical vasoconstriction induced by acetyl-choline in atherosclerosic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
11. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth mucle by acetycholine. Nature 1980; 288: 373-376.
12. Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patient with coronary artery disease. N Engl J Med 1995; 332: 481-487.
13. Anderson TJ, Meredith IT, Yeug AC, Frei B, Selwin AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy in the endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-493.
14. Leung WH, Lau CP, Wong CK. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341: 1496-1500.
15. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation 1994; 89: 2519-2524.
16. Ganz W, Tamura K, Markus HS, Donoso R, Yosida S, Swan HJC. Mesurement of coronary sinus blood flow by continuous thermodilution in man. Circulation 1971; 44: 181-195.
17. Zehier AM, Drexler H, Wollschlyger H, Just H. Modulation of coronary vascular tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
18. Cerlermajer DS, Orensen KE, Bull C, Robinson J, Deanfield JD. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24: 1468-1474.
19. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM et al. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95: 1747-1755.
20. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest 1997; 100: 2153-2157.
21. De Lombera F, Fernández S, Gascuena R, Lázaro M, Hernández P, Saavedra J et al. Hipertensión y dislipidemia. Rev Esp Cardiol 1998; 51 (Supl 4): 24-35.
22. Casanovas JA, Serrano P, Ferreira IJ. Obesidad e hipertensión arterial. Rev Esp Cardiol 1998; 51 (Supl 4): 15-18.
23. González I, Roldán I, Armada E, Pereira J, González I. Hipertensión arterial y alteraciones en el metabolismo hidrocarbono. Rev Esp Cardiol 1998; 51 (Supl 4): 3-14.
24. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
25. Verheuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MO, Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. Circ Res 1986; 58: 783-789.
26. Shimokawa H, Vanhoutte PM. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ Res 1989; 64: 900-914.
27. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S et al. Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis. Circulation 1999; 99: 1141-1146.
28. Yasue H, Matsuyama K, Okamura K, Morikami Y, Ogawa H. Response of angiographically normal human coronary arteries to intracoronary injection of acetilcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 1990; 81: 482-490.
29. Mancini GB, Henry GC, Macaya C, O'Neill BJ, Pucillo AL, Carere RG et al. Angiotensin-converting enzyme: inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 94: 258-265.
30. Gilligan DM, Quyyumi AA, Canon RO. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-2551.
31. Gómez-Hospital JA, Sabaté M, Cequier A, Alió J, Mauri J, Iràculis E et al. Función endotelial en segmentos arteriales previamente sometidos a angioplastia coronaria. Rev Esp Cardiol 2000; 53: 1467-1473.
32. Tamai O, Matsuoka H, Itabe H, Wada Y, Konho K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation 1997; 95: 76-82.
33. Brown BG, Albers JJ, Fisher L, Schaefer SM, Lin JT, Kaplan C et al. Regression of coronary artery disease as a result of intensive lipid lowering therapyin men wiyh high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298.
34. Watts GF, Lewis B, Brunt JNH, Lewis ES, Coltart TJ, Smith DLR et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' atherosclerosis regression study (STARS). Lancet 1992; 339: 563-569.
35. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659-1664.